Ness Ziona, Israel · Founded 2018 · Privately Held (backing)
Developer of a bio-pharmaceutical platform designed to develop proprietary small-molecule inhibitors. Kamari Pharma is based in Ness Ziona, Israel and was founded in 2018. Its last reported valuation was $42.8 million in Jun 2025. It has raised $48 million.
Last reported valuation
$42.8M
Oct 2026
Priced at
—
Total raised
$48.0M
Last round
—
Cap table — not yet on record
Kamari Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kamari Pharma with a free account
·Watch Kamari Pharma: the Monday email on marks, rounds and moves
